Showing results (1781-1790 of 1,922) with videos related to
Sort By:
Pageof 193
Current Neuropharmacology|January 3, 2017
Advantages of Structure-Based Drug Design Approaches in Neurological DisordersMurali Aarthy, Umesh Panwar, Chandrabose Selvaraj, et al.Current Neuropharmacology|March 27, 2014
Association of oxidative stress to the genesis of anxiety: implications for possible therapeutic interventionsWaseem Hassan, Carlos Eduardo Barroso Silva, Imdad Ullah Mohammadzai, et al.Current Neuropharmacology|March 27, 2014
Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the AmygdalaGeorge Anderson, Michael MaesCurrent Neuropharmacology|March 27, 2014
Metformin Eased Cognitive Impairment Induced by Chronic L-methionine Administration: Potential Role of Oxidative StressKarem H Alzoubi, Omar F Khabour, Sayer I Al-Azzam, et al.Current Neuropharmacology|March 27, 2014
Oxidative imbalance and anxiety disordersKrolow R, Arcego D M, Noschang C, et al.Current Neuropharmacology|March 27, 2014
Individual differences in the neurobiology of social stress: implications for depression-cardiovascular disease comorbiditySusan K WoodCurrent Neuropharmacology|December 7, 2016
Development of MLR and SVM Aided QSAR Models to Identify Common SAR of GABA Uptake Herbal Inhibitors used in the Treatment of SchizophreniaSahila Mohammed Marunnan, Babitha Pallikkara Pulikkal, Anitha Jabamalairaj, et al.Current Neuropharmacology|February 18, 2014
Purinergic signaling and hippocampal long-term potentiationRobert Düster, Jos Prickaerts, Arjan BloklandCurrent Neuropharmacology|November 9, 2018
Systematic Review of Food Addiction as Measured with the Yale Food Addiction Scale: Implications for the Food Addiction ConstructLouise Penzenstadler, Carina Soares, Laurent Karila, et al.Current Neuropharmacology|March 22, 2017
Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive DisorderZoya Marinova, De-Maw Chuang, Naomi FinebergPageof 193